NDAINJECTIONINJECTABLE
Approved
Feb 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 6h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Netromycin (netilmicin sulfate) is an aminoglycoside antibiotic administered by injection for treatment of serious gram-negative bacterial infections. It works by inhibiting bacterial protein synthesis through ribosomal binding. The drug targets hospitalized patients with severe infections where broad-spectrum coverage is clinically indicated.
LOE Approaching
With LOE approaching and moderate competitive pressure, the brand team is likely in consolidation mode with focused commercial resources on key accounts and hospital systems.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Netromycin offers limited career growth opportunity given its LOE status and minimal linked job openings. Roles focus on hospital relationships and competitive defense rather than market expansion or innovation.
Hospital Account ManagerRegional Sales Manager
Worked on NETROMYCIN at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.